30th Apr 2019 17:25
LONDON (Alliance News) - Proteome Sciences PLC, at its annual general meeting on Tuesday, said it experienced a "good" first quarter.
"As indicated in our recent results, we remain optimistic about the future, with the near-term availability of higher-plex TMT set to add significant value to this asset, and the utility of quantitative proteomics increasing in response to diagnostic advances and disruptive technologies," said Chair Christopher Pearce.
Pearce added that the company had a "good" first quarter, with growth in TMT sales and royalities and an improving services business continuing the trend in orders and revenue seen during the latter part of 2018.
Proteome Sciences shares closed up 6.1% at 2.8 pence on Tuesday.
Related Shares:
Proteome